Cargando…

LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1

PURPOSE: The purpose of this study was to investigate the clinical significance of LIMD1 and its biological roles in gastric cancer (GC). MATERIALS AND METHODS: The prognostic value of LIMD1 in GC patients was determined by the online tool Kaplan–Meier Plotter. The biological functions of LIMD1 in G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Di, Li, Song, Yu, Wenbin, Chen, Cheng, Liu, Teng, Sun, Yiting, Zhao, Zeyi, Liu, Lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188213/ https://www.ncbi.nlm.nih.gov/pubmed/30349368 http://dx.doi.org/10.2147/CMAR.S174856

Ejemplares similares

CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR
por: Sun, Yiting, et al.
Publicado: (2020)

LIMD1‐AS1 suppressed non‐small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U
por: Pan, Jianyuan, et al.
Publicado: (2020)

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
por: Chen, Zhigang, et al.
Publicado: (2023)

LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
por: Chen, Yuanmei, et al.
Publicado: (2021)

PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1
por: Foxler, Daniel E., et al.
Publicado: (2011)

AJUBA and WTIP can compete with LIMD1 for junctional localization and LATS regulation
por: Kirichenko, Elmira, et al.
Publicado: (2022)

Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
por: Zhang, Rui, et al.
Publicado: (2023)

N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer
por: Sun, Yiting, et al.
Publicado: (2020)

LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications
por: Ghosh, Susmita, et al.
Publicado: (2010)

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
por: Landry, Natalie M., et al.
Publicado: (2021)

Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
por: Davidson, Kathryn, et al.
Publicado: (2021)

A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
por: Foxler, Daniel E, et al.
Publicado: (2018)

Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell
por: Hou, Xiaobin, et al.
Publicado: (2016)

AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
por: Zhou, Yuhang, et al.
Publicado: (2020)

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
por: Yan, Cheng, et al.
Publicado: (2022)

miR-550a-5p Functions as a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma
por: Guo, Zi-Zhang, et al.
Publicado: (2020)

LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death
por: Wang, Ling, et al.
Publicado: (2017)

Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma
por: Wang, Ling, et al.
Publicado: (2021)

LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway
por: Chen, Lixin, et al.
Publicado: (2021)

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
por: Zhou, Qimin, et al.
Publicado: (2020)

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway
por: Zeng, Xiaofei, et al.
Publicado: (2020)

ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
por: Yu, Shiyi, et al.
Publicado: (2019)

NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein
por: Guo, Hui, et al.
Publicado: (2021)

Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy
por: Yan, Hongzhu, et al.
Publicado: (2018)

LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
por: Araldi, Rodrigo Pinheiro, et al.
Publicado: (2020)

Suppression of YAP by DDP disrupts colon tumor progression
por: Li, Kun, et al.
Publicado: (2018)

Suppression of YAP by DDP disrupts colon tumor progression
por: Li, Kun, et al.
Publicado: (2021)

The prognostic value of YAP1 on clinical outcomes in human cancers
por: Wu, Ying, et al.
Publicado: (2019)

Corrigendum: NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein
por: Guo, Hui, et al.
Publicado: (2021)

Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer
por: Sun, Hui, et al.
Publicado: (2018)

YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of gastric carcinoma
por: Guo, Zijun, et al.
Publicado: (2023)

Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1
por: Wang, Jianlin, et al.
Publicado: (2019)

CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer
por: Yu, Site, et al.
Publicado: (2019)

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)
por: Sun, Xujie, et al.
Publicado: (2022)

Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer
por: Li, Dan, et al.
Publicado: (2015)

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma
por: Frost, Thomas C., et al.
Publicado: (2023)

Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling
por: Liu, Qing, et al.
Publicado: (2020)

Circular RNA YAP1: a new player in gastric cancer
por: Verduci, Lorena, et al.
Publicado: (2019)

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_206mor97uuggtcctur26qghu44